Portfolio (Quarterly)
Guide ↗
Lion Point Capital, LP
· CIK 0001643354| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | DYN | DYNE THERAPEUTICS INC | Healthcare | 18,000.0 | $326K | 1.95% | — | — | $18.13 | +31.2% |
| 22 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 86,000.0 | $308K | 1.84% | — | — | $3.58 | +1.7% |
| 23 | PCRX | PACIRA BIOSCIENCES INC | Healthcare | 13,500.0 | $305K | 1.82% | — | — | $22.60 | +10.7% |
| 24 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 9,100.0 | $287K | 1.71% | — | — | $31.50 | +26.1% |
| 25 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 10,500.0 | $284K | 1.70% | — | — | $27.09 | +0.7% |
| 26 | MCRB | SERES THERAPEUTICS INC | Healthcare | 31,570.0 | $280K | 1.67% | — | — | $8.87 | -39.8% |
| 27 | JANX | JANUX THERAPEUTICS INC | Healthcare | 19,000.0 | $264K | 1.58% | — | — | $13.90 | +13.5% |
| 28 | QURE | UNIQURE NV | Healthcare | 14,700.0 | $240K | 1.44% | — | — | $16.35 | +153.9% |
| 29 | RGNX | REGENXBIO INC | Healthcare | 26,600.0 | $223K | 1.33% | — | — | $8.38 | +46.7% |
| 30 | AZTA | AZENTA INC | Healthcare | 9,700.0 | $205K | 1.23% | — | — | $21.13 | +20.4% |
| 31 | INVA | INNOVIVA INC | Healthcare | 8,200.0 | $191K | 1.14% | — | — | $23.30 | -6.7% |
| 32 | GHRS | GH RESEARCH PLC | Healthcare | 10,200.0 | $143K | 0.86% | — | — | $14.06 | +90.4% |
| 33 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 5,250.0 | $124K | 0.74% | — | — | $23.56 | +13.8% |
| 34 | IPHA | INNATE PHARMA S A | Healthcare | 81,151.0 | $104K | 0.62% | — | — | $1.28 | +39.8% |
| 35 | SPRB | SPRUCE BIOSCIENCES INC | Healthcare | 1,000.0 | $65K | 0.39% | — | — | $65.35 | -29.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%